Contact this trialFirst, we need to learn more about you.
Enzyme Replacement Therapy
Tividenofusp Alfa for Hunter Syndrome
Recruiting1 awardPhase 2 & 3
Chapel Hill, North Carolina
This trial will study the safety, tolerability, and efficacy of an investigational therapy for Hunter Syndrome (MPS II) for up to 5 years. Participants, site staff, & the Sponsor remain blinded to the treatment assignment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.